University Involvement
Early on, Emory and its researchers recognized the importance of HIV/AIDS research. Research was conducted in different departments all over the campus prior to 1997, when the Emory Center for Aids Research began to integrate efforts from all corners of the University, encourage interdisciplinary research and raise the profile of the study of HIV/AIDS.
Emory understood the significance of the break-through innovations developed by their researchers, and went to great lengths, financial and otherwise, to preserve their inventors' rights in their intellectual property. When called upon, Emory aggressively and proactively defended its researchers, utilizing the legal system as well as the tenets of the U.S. Patent Office.
Legal Filings/Proceedings
Emory University v Glaxo Wellcome, Inc., et al
Counter Claims by Glaxo Wellcome & BioChem Pharmaceuticals v Emory University
- Plaintiff Assertions: Emory filed suit against Glaxo Wellcome and BioChem Pharma for patent infringement.
- Damages Sought: Unspecified
- Filed: July 23, 1996
- Defendant Assertions: Glaxo, et al fought to establish BioChem's patent rights in the U.S., despite BioChem's Canadian location. For research conducted outside of the U.S., specific deadlines for patent filing exist.
- Counterclaim: Glaxo's counterclaim was similar to its defense, based on their claims of the precedence of BioChem's patents and claimed Emory's patent is invalid.
|
